25
Sep
Sep
Molnupiravir, an antiviral drug used to treat patients with COVID-19, appears to be driving SARS-CoV-2 to mutate and evolve, with a few of these recent viruses being transmitted onwards, a brand new study has shown. It will not be clear, nonetheless, whether these mutated viruses pose an increased risk to patients or are in a […]